Skip to main content
Have a personal or library account? Click to login
A Comparative Study of Predictive Models for Postoperative Pancreatic Fistula: Assessing the Original Fistula Risk Score and Duct-to-Parenchyma Ratio in a cohort of Pakistani Population Cover

A Comparative Study of Predictive Models for Postoperative Pancreatic Fistula: Assessing the Original Fistula Risk Score and Duct-to-Parenchyma Ratio in a cohort of Pakistani Population

Open Access
|Nov 2026
Read online

Figures & tables

Table 1.

Univariate Analysis.

FactorsMean, Median/IQRNumber (percentages)Fistula PresenceP-Value
YesNO
Age in yearsMean: 50.49±13.0318–30 years 10 (8.8)190.785
31–50 years 41 (36)932
51–70 years 57 (50)948
71 years & above 6 (5.3)15
GenderMale: 67 (58.8)16510.034*
Female: 47 (41.2)443
BMI in kgMean:24.74±4.53Underweight 12 (10.5)390.198
Healthy weight 46 (40.4)541
Overweight 43 (37.7)1132
Obesity 13 (11.4)112
Duct Size mmMedian:2.70Duct size <3mm 66 (58)16500.044*
IQR: 1.80–4.20Duct size >3mm 48 (42)444
Duct to Parenchyma RationMean: 0.261±1.52High risk (<0.25): 61 (53.5)16460.013*
Low risk (>0.25): 53 (46.5)448
Fistula risk scoreMean: 4.38±2.05Low risk: 252230.004*
Medium risk: 711061
High risk: 18810
Gland consistencySoft 71 (62.28)14570.940
Hard 43 (37.72)637
Post-operative histopathologyModerately diff- Adenocarcinoma 64 (56)10540.552
Poorly diff- Adenocarcinoma 15 (13)114
Well diff-Adenocarcinoma 17 (15)611
Well to mod-diff adenocarcinoma 1 (0.9)01
Neuroendocrine tumour Grade-I 2 (1.8)02
Neuroendocrine tumour Grade -II 2 (1.8)11
Neuroendocrine tumour Grade -III 3 (2.6)12
Pseudopapillary neoplasm 2 (1.8)02
Intraductal papillary mucinous neoplasm 2 (1.8)02
Chronic Pancreatitis 5 (4.4)14
Tubulovillious Adenoma 1 (0.9)01
Blood loss in mlMedian: 200 mlLess than 500 ml: 103 (90)19840.717
IQR:100–300 ml500ml–1000 ml: 10 (8.8)19
More than 1000ml: 1 (0.9)01

[i] diff-Aden: differentiated Adenocarcinoma, mod-diff: moderately differentiated Adenocarcinoma, BMI: Body mass index, IQR: Inter-quartile range, ml: millilitres, mm: millimeters.

Figure 1.

ROC (Receiver Operating Characteristic) curve for original Fistula Risk Score (o-FRS) and duct-to-parenchyma ratio (DPR).

Table 2.

Area under curve (AUC) analysis of o-FRS and DPR with corresponding significance and confidence intervals.

SNTest variableArea under curveConfidence intervalLevel of significanceStandard error
1O-FRS0.7090.577–0.8410.0030.067
2DPR0.2320.132–0.3320.0000.051

[i] o-FRS: orignal fistula risk score, DPR: Duct to parenchyma ratio.

Table 3.

Multivariate Logistic regression.

VariablesOdds RatioConfidence IntervalP-value
Age0.990.95–1.040.932
BMI0.960.86–1.070.520
Gland consistency
soft0.8220.254–2.6630.744
hard
Duct size in mm0.430.23–0.780.006*
Gender
maleReference
female3.961.09–4.380.036*
Blood loss in ml0.9980.994–1.000.214

[i] BMI: Body mass index, ml: millilitres, mm: millimeters.

Figure 2.

ROC (Receiver Operating Characteristic) curve for individual factors.

Table 4.

Area under curve (AUC) analysis of individual factors with corresponding significance and confidence intervals.

FactorsArea Under the curveLevel of significanceConfidence interval
Blood loss0.3690.0660.23–0.49
Duct size in mm0.2670.001*0.15–0.38
Age0.4620.5960.31–0.60
BMI0.5170.8070.37–0.65
Table 5.

Diagnostic Accuracy of DPR and o-FRS in Predicting CR-POPF: Sensitivity, Specificity, and Predictive Values.

Predictive scoresSensitivitySpecificityPositive predictive valueNegative predictive value
DPR0%76.2%0%68.1%
o-FRS22.1%91.9%85%36.2%
Language: English
Page range: 169 - 177
Published on: Nov 11, 2026
Published by: Shakuat Khanum Memorial Cancer Hospital and Research Centre
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Syed Irfan Kabir, Asad Ullah Khan, Mahnoor Asim, Mahnoor Durrani, Noor Ul Ain, Neelma, Fatima Gilani, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.